|
VDAC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.38229485822239E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.2584049881641E-11 |
| Normal-vs-Stage2 |
3.191100E-04 |
| Normal-vs-Stage3 |
1.079890E-02 |
| Normal-vs-Stage4 |
2.084600E-03 |
| Stage1-vs-Stage2 |
4.285400E-01 |
| Stage1-vs-Stage3 |
5.593900E-02 |
| Stage1-vs-Stage4 |
6.532800E-01 |
| Stage2-vs-Stage3 |
5.278300E-02 |
| Stage2-vs-Stage4 |
3.348800E-01 |
| Stage3-vs-Stage4 |
3.371400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.24139628868647E-11 |
| Normal-vs-AfricanAmerican |
6.385900E-02 |
| Normal-vs-Asian |
7.147200E-01 |
| Caucasian-vs-AfricanAmerican |
1.405220E-01 |
| Caucasian-vs-Asian |
4.547000E-01 |
| AfricanAmerican-vs-Asian |
8.646000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57180000126544E-08 |
| Normal-vs-Female |
1.77009999990929E-08 |
| Male-vs-Female |
8.133600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.136800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.01600000213776E-08 |
| Normal-vs-Age(61-80Yrs) |
1.43260000529111E-08 |
| Normal-vs-Age(81-100Yrs) |
2.321700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.779900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.756100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.917800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.044800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.909000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.342800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.228220E-01 |
| Normal-vs-Grade 2 |
1.24140000501427E-08 |
| Normal-vs-Grade 3 |
5.47170000420039E-08 |
| Normal-vs-Grade 4 |
4.462000E-02 |
| Grade 1-vs-Grade 2 |
7.147600E-01 |
| Grade 1-vs-Grade 3 |
6.209000E-01 |
| Grade 1-vs-Grade 4 |
8.446400E-01 |
| Grade 2-vs-Grade 3 |
5.289400E-01 |
| Grade 2-vs-Grade 4 |
2.960600E-01 |
| Grade 3-vs-Grade 4 |
1.588360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.4432899320127E-15 |
| Normal-vs-ccB subtype |
4.704300E-03 |
| ccA subtype-vs-ccB subtype |
3.988200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.33740000027605E-07 |
| Normal-vs-N1 |
2.286200E-01 |
| N0-vs-N1 |
8.593000E-01 |
|
|
